HealthCor Management as of Sept. 30, 2017
Portfolio Holdings for HealthCor Management
HealthCor Management holds 36 positions in its portfolio as reported in the September 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY) | 8.4 | $251M | 1.0M | 251.23 | |
| Laboratory Corp Amer Hldgs Com New | 8.0 | $237M | 1.6M | 150.97 | |
| Bioverativ Inc Com equity | 7.9 | $237M | 4.2M | 57.07 | |
| Zimmer Holdings Call Option (ZBH) | 7.6 | $228M | 1.9M | 117.09 | |
| Aetna | 6.0 | $180M | 1.1M | 159.01 | |
| Mallinckrodt Pub SHS Call Option | 5.0 | $150M | 4.0M | 37.37 | |
| Allergan SHS Call Option | 5.0 | $148M | 723k | 204.95 | |
| Neurocrine Biosciences (NBIX) | 4.3 | $128M | 2.1M | 61.28 | |
| Danaher Corporation (DHR) | 3.6 | $107M | 1.3M | 85.78 | |
| Pacira Pharmaceuticals (PCRX) | 3.2 | $97M | 2.6M | 37.55 | |
| Johnson & Johnson (JNJ) | 3.0 | $89M | 683k | 130.01 | |
| Abbvie (ABBV) | 2.9 | $88M | 986k | 88.86 | |
| Celgene Corporation | 2.7 | $79M | 543k | 145.82 | |
| UnitedHealth (UNH) | 2.5 | $75M | 383k | 195.85 | |
| Tenet Healthcare Corp Com New (THC) | 2.5 | $75M | 4.5M | 16.43 | |
| Incyte Corporation (INCY) | 2.3 | $70M | 599k | 116.74 | |
| Livanova SHS (LIVN) | 2.2 | $65M | 932k | 70.06 | |
| Sarepta Therapeutics Call Option (SRPT) | 2.2 | $65M | 1.4M | 45.36 | |
| Haemonetics Corporation (HAE) | 2.2 | $65M | 1.5M | 44.87 | |
| Humana (HUM) | 2.1 | $64M | 261k | 243.63 | |
| Clovis Oncology | 1.8 | $53M | 647k | 82.40 | |
| Varian Medical Systems Put Option | 1.7 | $50M | 500k | 100.06 | |
| Inc Resh Hldgs Cl A | 1.6 | $49M | 931k | 52.30 | |
| Merck & Co (MRK) | 1.5 | $44M | 691k | 64.03 | |
| Hill-Rom Holdings | 1.5 | $43M | 585k | 74.00 | |
| Five Prime Therapeutics | 1.4 | $41M | 1.0M | 40.91 | |
| Edwards Lifesciences (EW) | 1.2 | $37M | 339k | 109.31 | |
| Corindus Vascular Robotics I | 1.0 | $30M | 20M | 1.52 | |
| Select Sector Spdr Tr Sbi Healthcare (XLV) | 1.0 | $29M | 354k | 81.73 | |
| Intuitive Surgical Com New (ISRG) | 0.9 | $26M | 25k | 1045.89 | |
| Zoetis Cl A (ZTS) | 0.9 | $25M | 399k | 63.76 | |
| Boston Scientific Corporation (BSX) | 0.7 | $20M | 687k | 29.17 | |
| Bristol Myers Squibb (BMY) | 0.6 | $19M | 291k | 63.74 | |
| Pfizer (PFE) | 0.3 | $8.8M | 248k | 35.70 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 0.2 | $5.3M | 35k | 152.05 | |
| Medtronic SHS (MDT) | 0.2 | $5.1M | 66k | 77.78 |
